Sfoglia per RIVISTA
TRANSLATIONAL LUNG CANCER RESEARCH
Collezione ASL Torino 4

  

Items : 4

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2022 May;11(5):935-949. doi: 10.21037/tlcr-22-1.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Garbo E; Listì A; Bertaglia V; Bironzo P; Passiglia F; Scagliotti GV;

Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study. in Translational lung cancer research / Transl Lung Cancer Res. 2022 May;11(5):757-775. doi: 10.21037/tlcr-22-300.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Shen B; Wang X; Bironzo P; Spitaleri G; Hofman P; Peng W; Zhu M; Wang R; Xia J; Chen Y; Du X; Wen S;

Rate and risk factors of recurrent immune checkpoint inhibitor-related pneumonitis in patients with lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Mar;11(3):381-392. doi: 10.21037/tlcr-22-168.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Passiglia F; Leong TL; Facchinetti F; Liu B; Wang L; Liu Q; Ji S; Wu D; Li F; Tao H; Hu Y;

Expert consensus on perioperative treatment for non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Jul;11(7):1247-1267. doi: 10.21037/tlcr-22-527.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Sakanoue I; Rodriguez M; Owen DH; Novoa NM; Minervini F; Metro G; Lin SH; Kim JJ; John T; Gridelli C; Gobbini E; Brunelli A; Fiorelli A; Bongiolatti S; Zhou Q; Zhou Q; Zhou C; Ying J; Yang N; Yao Y; Wang Q; Yang F; Wang J; Shi M; Lu Y; Long H; Jiang T; Huang Y; Hu J; et alii...